Hepatocellular Carcinoma: Current Management and Future Development—Improved Outcomes with Surgical Resection

Currently, surgical resection is the treatment strategy offering the best long-term outcomes in patients with hepatocellular carcinoma (HCC). Especially for advanced HCC, surgical resection is the only strategy that is potentially curative, and the indications for surgical resection have expanded concomitantly with the technical advances in hepatectomy. A major problem is the high recurrence rate even after curative resection, especially in the remnant liver. Although repeat hepatectomy may prolong survival, the suitability may be limited due to multiple tumor recurrence or background liver cirrhosis. Multimodality approaches combining other local ablation or systemic therapy may help improve the prognosis. On the other hand, minimally invasive, or laparoscopic, hepatectomy has become popular over the last decade. Although the short-term safety and feasibility has been established, the long-term outcomes have not yet been adequately evaluated. Liver transplantation for HCC is also a possible option. Given the current situation of donor shortage, however, other local treatments should be considered as the first choice as long as liver function is maintained. Non-transplant treatment as a bridge to transplantation also helps in decreasing the risk of tumor progression or death during the waiting period. The optimal timing for transplantation after HCC recurrence remains to be investigated.

[1]  A. Luciani,et al.  Liver Resection for Transplantable Hepatocellular Carcinoma: Long-Term Survival and Role of Secondary Liver Transplantation , 2009, Annals of surgery.

[2]  G. Gerunda,et al.  Role of transarterial chemoembolization before liver resection for hepatocarcinoma , 2000, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[3]  D. Geller,et al.  World Review of Laparoscopic Liver Resection—2,804 Patients , 2009, Annals of surgery.

[4]  M. Makuuchi,et al.  Ultrasonically guided subsegmentectomy. , 1985, Surgery, gynecology & obstetrics.

[5]  K. Sugimachi,et al.  Repeat hepatectomy is the most useful treatment for recurrent hepatocellular carcinoma. , 2001, Journal of hepato-biliary-pancreatic surgery.

[6]  ndrea,et al.  Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. , 1996, The New England journal of medicine.

[7]  E. Abdalla,et al.  Resection Prior to Liver Transplantation for Hepatocellular Carcinoma , 2003, Annals of surgery.

[8]  Bixiang Zhang,et al.  Role of Mesohepatectomy with or without Transcatheter Arterial Chemoembolization for Large Centrally Located Hepatocellular Carcinoma , 2007, Digestive Surgery.

[9]  M. Makuuchi,et al.  One thousand fifty-six hepatectomies without mortality in 8 years. , 2003, Archives of surgery.

[10]  K. Tanikawa,et al.  Predictive factors for long term prognosis after partial hepatectomy for patients with hepatocellular carcinoma in Japan. The liver cancer study group of japan , 1994, Cancer.

[11]  S. Arii,et al.  Characteristics of recurrent hepatocellular carcinoma in Japan and our surgical experience. , 2001, Journal of hepato-biliary-pancreatic surgery.

[12]  Brice Gayet,et al.  The International Position on Laparoscopic Liver Surgery: The Louisville Statement, 2008 , 2009, Annals of surgery.

[13]  T. Mala,et al.  Laparoscopic liver resection for malignant and benign lesions: ten-year Norwegian single-center experience. , 2010, Archives of surgery.

[14]  Y. Sakamoto,et al.  Efficacy of a Hepatectomy and a Tumor Thrombectomy for Hepatocellular Carcinoma with Tumor Thrombus Extending to the Main Portal Vein , 2009, Journal of Gastrointestinal Surgery.

[15]  Yong Zeng,et al.  A Randomized Trial Comparing Radiofrequency Ablation and Surgical Resection for HCC Conforming to the Milan Criteria , 2010, Annals of surgery.

[16]  R. Parks,et al.  Perioperative chemotherapy with FOLFOX 4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer ( EORTC Intergroup trial 40983 ) : a randomised controlled trial , 2008 .

[17]  Y. Takeda,et al.  Patterns and clinicopathologic features of extrahepatic recurrence of hepatocellular carcinoma after curative resection. , 2007, Surgery.

[18]  Fan Zhou,et al.  Adjuvant transcatheter arterial chemoembolization improves efficacy of hepatectomy for patients with hepatocellular carcinoma and portal vein tumor thrombus. , 2009, American journal of surgery.

[19]  W. Lau,et al.  Surgical Treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus , 2010, Annals of Surgical Oncology.

[20]  K. Shirabe,et al.  Prognosis of recurrent hepatocellular carcinoma: a 10-year surgical experience in Japan. , 1996, Gastroenterology.

[21]  Jung‐Ta Chen,et al.  An appraisal of liver and portal vein resection for hepatocellular carcinoma with tumor thrombi extending to portal bifurcation. , 2000, Archives of surgery.

[22]  M. Nagao,et al.  Repeat liver resection for hepatocellular carcinoma. , 2001, Journal of the American College of Surgeons.

[23]  K. Sung,et al.  Sequential Preoperative Ipsilateral Hepatic Vein Embolization After Portal Vein Embolization to Induce Further Liver Regeneration in Patients With Hepatobiliary Malignancy , 2009, Annals of surgery.

[24]  Xuan Li,et al.  An aggressive approach leads to improved survival in hepatocellular carcinoma patients with portal vein tumor thrombus , 2010, Journal of Cancer Research and Clinical Oncology.

[25]  J. Bruix,et al.  Prognosis of Hepatocellular Carcinoma: The BCLC Staging Classification , 1999, Seminars in liver disease.

[26]  Zeng-chen Ma,et al.  Improved Survival with Resectionafter Transcatheter ArterialChemoembolization (TACE) for Unresectable Hepatocellular Carcinoma , 1998, Digestive Surgery.

[27]  Y. Maetani,et al.  Living donor liver transplantation as a second‐line therapeutic strategy for patients with hepatocellular carcinoma , 2006, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[28]  R. Poon,et al.  Intrahepatic recurrence after curative resection of hepatocellular carcinoma: long-term results of treatment and prognostic factors. , 1999, Annals of surgery.

[29]  W. Lau,et al.  Salvage Surgery Following Downstaging of Unresectable Hepatocellular Carcinoma , 2004, Annals of surgery.

[30]  S. Fan,et al.  Selection criteria for hepatic resection in patients with large hepatocellular carcinoma larger than 10 cm in diameter. , 2002, Journal of the American College of Surgeons.

[31]  J. Vauthey,et al.  Factors affecting long-term outcome after hepatic resection for hepatocellular carcinoma. , 1995, American journal of surgery.

[32]  G. Dusheiko,et al.  Management of hepatocellular carcinoma. , 1992, Journal of hepatology.

[33]  D. Lu,et al.  Liver Transplantation Criteria For Hepatocellular Carcinoma Should Be Expanded: A 22-Year Experience With 467 Patients at UCLA , 2007, Annals of surgery.

[34]  R. Stephenson A and V , 1962, The British journal of ophthalmology.

[35]  Ding‐Shinn Chen,et al.  Percutaneous Ethanol Injection Versus Surgical Resection for the Treatment of Small Hepatocellular Carcinoma: A Prospective Study , 2005, Annals of surgery.

[36]  M. Makuuchi,et al.  Surgical management for adrenal gland metastasis of hepatocellular carcinoma. , 1999, Hepato-gastroenterology.

[37]  Ho‐Seong Han,et al.  Feasibility of laparoscopic liver resection for tumors located in the posterosuperior segments of the liver, with a special reference to overcoming current limitations on tumor location. , 2008, Surgery.

[38]  S. Fan,et al.  Hepatectomy for hepatocellular carcinoma: toward zero hospital deaths. , 1999, Annals of surgery.

[39]  W. Lau,et al.  A Prospective, Randomized, Controlled Trial of Preoperative Transarterial Chemoembolization for Resectable Large Hepatocellular Carcinoma , 2009, Annals of surgery.

[40]  Surgery or ablation for hepatocellular carcinoma. , 2009, Annals of surgery.

[41]  Thomas Gruenberger,et al.  Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial , 2008, The Lancet.

[42]  S. Fan,et al.  Aggressive management of patients with extrahepatic and intrahepatic recurrences of hepatocellular carcinoma by combined resection and locoregional therapy. , 2002, Journal of the American College of Surgeons.

[43]  V. Mazzaferro,et al.  Resection, transplantation, either, or both? Other pieces of the puzzle , 2005, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[44]  V. Vilgrain,et al.  Sequential arterial and portal vein embolizations before right hepatectomy in patients with cirrhosis and hepatocellular carcinoma , 2006, The British journal of surgery.

[45]  Z. Tang,et al.  Improved survival with resection after transcatheter arterial chemoembolization (TACE) for unresectable hepatocellular carcinoma. , 1998, Digestive surgery.

[46]  T. Pawlik,et al.  Hepatectomy for hepatocellular carcinoma with major portal or hepatic vein invasion: results of a multicenter study. , 2005, Surgery.

[47]  H. Hasegawa,et al.  A Prospective Randomized Trial of the Preventive Effect of Pre‐operative Transcatheter Arterial Embolization against Recurrence of Hepatocellular Carcinoma , 1996, Japanese journal of cancer research : Gann.

[48]  J. Joh,et al.  Liver transplantation for adult patients with hepatocellular carcinoma in Korea: Comparison between cadaveric donor and living donor liver transplantations , 2005, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[49]  Tse-Ching Chen,et al.  Efficacy of surgical resection in management of isolated extrahepatic metastases of hepatocellular carcinoma. , 2009, World journal of gastroenterology.

[50]  H. Eguchi,et al.  The significance of surgical resection for pulmonary metastasis from hepatocellular carcinoma. , 2006, American journal of surgery.

[51]  Y. Takeda,et al.  Interferon‐α and 5‐fluorouracil combination therapy after palliative hepatic resection in patients with advanced hepatocellular carcinoma, portal venous tumor thrombus in the major trunk, and multiple nodules , 2007, Cancer.

[52]  C. Ker,et al.  The effect of preoperative transarterial chemoembolization of resectable hepatocellular carcinoma on clinical and economic outcomes , 2009, Journal of surgical oncology.

[53]  Alan J. Koffron,et al.  Evaluation of 300 Minimally Invasive Liver Resections at a Single Institution: Less Is More , 2007, Annals of surgery.

[54]  Cheng‐Chung Wu,et al.  Second and third hepatectomies for recurrent hepatocellular carcinoma are justified , 2009, The British journal of surgery.

[55]  Dieter Häussinger,et al.  Sorafenib in advanced hepatocellular carcinoma. , 2008, The New England journal of medicine.

[56]  E. Gregoire,et al.  Resection of hepatocellular carcinoma with tumor thrombus in the major vasculature. A European case-control series , 2006, Journal of Gastrointestinal Surgery.

[57]  M. Makuuchi,et al.  Living Donor Liver Transplantation for Hepatocellular Carcinoma: Tokyo University Series , 2007, Digestive Diseases.

[58]  Yih-Leong Chang,et al.  Prognostic Factors for Pulmonary Metastasectomy in Hepatocellular Carcinoma , 2006, Annals of Surgical Oncology.

[59]  Y. Maehara,et al.  Extended Indication for Living Donor Liver Transplantation in Patients With Hepatocellular Carcinoma , 2007, Transplantation.

[60]  S. Paggi,et al.  Sorafenib in Advanced Hepatocellular Carcinoma , 2008 .

[61]  Miss A.O. Penney (b) , 1974, The New Yale Book of Quotations.

[62]  Y. Takeda,et al.  Prognosis of hepatocellular carcinoma with biliary tumor thrombi after liver surgery. , 2011, Surgery.

[63]  M. Makuuchi,et al.  Preemptive Therapy for Hepatitis C Virus after Living-Donor Liver Transplantation , 2004, Transplantation.

[64]  J. Bruix,et al.  Intention‐to‐treat analysis of surgical treatment for early hepatocellular carcinoma: Resection versus transplantation , 1999, Hepatology.

[65]  R. Baron,et al.  Extrahepatic metastases of hepatocellular carcinoma. , 2000, Radiology.

[66]  F. P'eng,et al.  Preoperative transcatheter arterial chemoembolization for resectable large hepatocellular carcinoma: A reappraisal , 1995, The British journal of surgery.

[67]  V. Paradis,et al.  Hepatocellular carcinomas in patients with metabolic syndrome often develop without significant liver fibrosis: A pathological analysis , 2009, Hepatology.

[68]  W. Lau,et al.  A Prospective Randomized Trial Comparing Percutaneous Local Ablative Therapy and Partial Hepatectomy for Small Hepatocellular Carcinoma , 2006, Annals of surgery.

[69]  日本肝癌研究会 General rules for the clinical and pathological study of primary liver cancer , 2010 .

[70]  B. Xing,et al.  Radiofrequency ablation of recurrent hepatocellular carcinoma after hepatectomy: therapeutic efficacy on early- and late-phase recurrence. , 2006, AJR. American journal of roentgenology.

[71]  S. Curley,et al.  Major hepatic resection for hepatocellular carcinoma with or without portal vein embolization: Perioperative outcome and survival. , 2009, Surgery.

[72]  M. Tsuneyoshi,et al.  Effects of preoperative transcatheter hepatic arterial chemoembolization for hepatocellular carcinoma. The relationship between postoperative course and tumor necrosis , 1993, Cancer.

[73]  M. Makuuchi,et al.  Sequential preoperative arterial and portal venous embolizations in patients with hepatocellular carcinoma. , 2004, Archives of surgery.

[74]  S. Kawasaki,et al.  Prognostic significance of anatomical resection and des‐γ‐carboxy prothrombin in patients with hepatocellular carcinoma , 1999, The British journal of surgery.

[75]  A. Benson,et al.  Safety and efficacy of 90Y radiotherapy for hepatocellular carcinoma with and without portal vein thrombosis , 2007, Hepatology.

[76]  J. Figueras,et al.  Impact of immunosuppression without steroids on rejection and hepatitis C virus evolution after liver transplantation: Results of a prospective randomized study , 2008, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[77]  Ho‐Seong Han,et al.  Total laparoscopic liver resection for hepatocellular carcinoma located in all segments of the liver , 2010, Surgical Endoscopy.

[78]  S. Giulini,et al.  Sequential multidisciplinary treatment of hepatocellular carcinoma: The role of surgery as rescue therapy for failure of percutaneous ablation therapies , 2009, Journal of surgical oncology.

[79]  N. Nagasue,et al.  Role of Preoperative Transcatheter Arterial Oily Chemoembolization for Resectable Hepatocellular Carcinoma , 1996, World Journal of Surgery.

[80]  M. Gonen,et al.  Outcome of partial hepatectomy for large (> 10 cm) hepatocellular carcinoma , 2005, Cancer.

[81]  A. Ponti,et al.  The Learning Curve in Laparoscopic Liver Resection: Improved Feasibility and Reproducibility , 2009, Annals of surgery.

[82]  D. Suh,et al.  Pre‐operative transarterial chemoembolization for resectable hepatocellular carcinoma adversely affects post‐operative patient outcome , 2007, Alimentary pharmacology & therapeutics.

[83]  M. Abecassis,et al.  Yttrium‐90 microspheres (TheraSphere®) treatment of unresectable hepatocellular carcinoma: Downstaging to resection, RFA and bridge to transplantation , 2006, Journal of surgical oncology.

[84]  L Pagliaro,et al.  Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. , 2001, Journal of hepatology.

[85]  E. Hatano,et al.  Prognostic index for patients with hepatocellular carcinoma combined with tumor thrombosis in the major portal vein. , 2006, Journal of the American College of Surgeons.

[86]  L. Capussotti,et al.  Liver resection for HCC with cirrhosis: surgical perspectives out of EASL/AASLD guidelines. , 2009, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[87]  M. Makuuchi,et al.  Preoperative portal embolization to increase safety of major hepatectomy for hilar bile duct carcinoma: a preliminary report. , 1990, Surgery.

[88]  Bernard Paule,et al.  Rescue Surgery for Unresectable Colorectal Liver Metastases Downstaged by Chemotherapy: A Model to Predict Long-term Survival , 2004, Annals of surgery.

[89]  S. Yajima,et al.  Laparoscopic hepatectomy for hepatocellular carcinoma in cirrhotic patients. , 2009, Journal of hepato-biliary-pancreatic surgery.

[90]  M. Makuuchi,et al.  Is there any difference in survival according to the portal tumor thrombectomy method in patients with hepatocellular carcinoma? , 2009, Surgery.

[91]  S. Katagiri,et al.  Effectiveness of systematized hepatectomy with Glisson's pedicle transection at the hepatic hilus for small nodular hepatocellular carcinoma: retrospective analysis. , 2001, Surgery.

[92]  Yutaka Matsuyama,et al.  Development of evidence‐based clinical guidelines for the diagnosis and treatment of hepatocellular carcinoma in Japan , 2008, Hepatology research : the official journal of the Japan Society of Hepatology.

[93]  S. Fan,et al.  Transarterial chemoembolization for inoperable hepatocellular carcinoma and postresection intrahepatic recurrence , 2000, Journal of surgical oncology.

[94]  I. Bilbao,et al.  Resection for hepatocellular carcinoma is a good option in Child‐Turcotte‐Pugh class A patients with cirrhosis who are eligible for liver transplantation , 2005, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[95]  A. Venook,et al.  Liver transplantation for hepatocellular carcinoma: Expansion of the tumor size limits does not adversely impact survival , 2001, Hepatology.

[96]  T. Asahara,et al.  Repeat hepatectomy for recurrent hepatocellular carcinoma. , 2007, Surgery.

[97]  N. Nagasue,et al.  Repeat hepatectomy for recurrent hepatocellular carcinoma , 1996, The British journal of surgery.

[98]  S. Todo,et al.  The impact of anatomical resection for hepatocellular carcinoma that meets the milan criteria , 2010, Journal of surgical oncology.

[99]  W. Marsden I and J , 2012 .

[100]  Guy Brock,et al.  Experience With More Than 500 Minimally Invasive Hepatic Procedures , 2008, Annals of surgery.

[101]  S. Futagawa,et al.  Role of Preoperative Transcatheter Arterial Chemoembolization for Resectable Hepatocellular Carcinoma: Relation between Postoperative Course and the Pattern of Tumor Recurrence , 2003, World Journal of Surgery.

[102]  A. Zhu,et al.  Liver transplantation outcomes for early‐stage hepatocellular carcinoma: Results of a multicenter study , 2004, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[103]  H. Yoshida,et al.  Extrahepatic metastasis of hepatocellular carcinoma: incidence and risk factors , 2008, Liver international : official journal of the International Association for the Study of the Liver.

[104]  M. Makuuchi,et al.  Selection Criteria for Repeat Hepatectomy in Patients With Recurrent Hepatocellular Carcinoma , 2003, Annals of surgery.

[105]  S. Uemoto,et al.  Expansion of selection criteria for patients with hepatocellular carcinoma in living donor liver transplantation , 2007, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[106]  C. Wai,et al.  Long Term Outcome and Prognostic Factors for Large Hepatocellular Carcinoma (10 cm or more) after Surgical Resection , 2007, Annals of Surgical Oncology.

[107]  Byung Chul Yoo,et al.  Percutaneous Radiofrequency Ablation for Recurrent Hepatocellular Carcinoma After Hepatectomy: Long-term Results and Prognostic Factors , 2007, Annals of Surgical Oncology.

[108]  K. Saigenji,et al.  Repeat Radiofrequency Ablation Provides Survival Benefit in Patients With Intrahepatic Distant Recurrence of Hepatocellular Carcinoma , 2009, The American Journal of Gastroenterology.

[109]  J. Choi,et al.  Is Preoperative Transarterial Chemoembolization Needed for a Resectable Hepatocellular Carcinoma? , 2007, World Journal of Surgery.

[110]  G. Honda,et al.  Clinicopathologic evaluation of hepatocellular carcinoma with bile duct thrombi. , 2000, Surgery.

[111]  M. Makuuchi,et al.  Comparison of the outcomes between an anatomical subsegmentectomy and a non-anatomical minor hepatectomy for single hepatocellular carcinomas based on a Japanese nationwide survey. , 2008, Surgery.

[112]  G. Otto,et al.  Early Steroid-Free Immunosuppression With FK506 After Liver Transplantation: Long-Term Results of a Prospectively Randomized Double-Blinded Trial , 2010, Transplantation.

[113]  O. Matsui,et al.  Postoperative adjuvant hepatic arterial infusion of lipiodol containing anticancer drugs in patients with hepatocellular carcinoma , 1994, Hepatology.

[114]  N. O'Rourke,et al.  Laparoscopic right hepatectomy: Surgical technique , 2004, Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract.

[115]  J. Bruix,et al.  Natural history of untreated nonsurgical hepatocellular carcinoma: Rationale for the design and evaluation of therapeutic trials , 1999, Hepatology.

[116]  M. Omata,et al.  Combination therapy of intraarterial 5‐fluorouracil and systemic interferon‐alpha for advanced hepatocellular carcinoma with portal venous invasion , 2006, Cancer.

[117]  G. G. Stokes "J." , 1890, The New Yale Book of Quotations.

[118]  M. Makuuchi,et al.  Selection Criteria for Hepatectomy in Patients with Hepatocellular Carcinoma and Portal Vein Tumor Thrombus , 2001, Annals of surgery.

[119]  M. Makuuchi,et al.  Cyclosporin a for treatment of hepatitis C virus after liver transplantation. , 2006, Transplantation.

[120]  Y. Karino,et al.  Clinical features of hepatocellular carcinoma with extrahepatic metastases , 2005, Journal of gastroenterology and hepatology.

[121]  Alexis Laurent,et al.  Laparoscopic liver resection for subcapsular hepatocellular carcinoma complicating chronic liver disease. , 2003, Archives of surgery.

[122]  M. Makuuchi,et al.  Neither multiple tumors nor portal hypertension are surgical contraindications for hepatocellular carcinoma. , 2008, Gastroenterology.

[123]  L. Ellis,et al.  Pathologic response to preoperative chemotherapy: a new outcome end point after resection of hepatic colorectal metastases. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[124]  Y. Iwashita,et al.  Preoperative transcatheter arterial chemoembolization reduces long-term survival rate after hepatic resection for resectable hepatocellular carcinoma. , 2006, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[125]  Influence of transcatheter arterial chemoembolization on the prognosis after hepatectomy for hepatocellular carcinoma in patients with severe liver dysfunction. , 2006, Anticancer research.

[126]  T. Inoue,et al.  Is preoperative hepatic arterial chemoembolization safe and effective for hepatocellular carcinoma? , 1996, Annals of surgery.

[127]  F. Lévi,et al.  Complete pathologic response after preoperative chemotherapy for colorectal liver metastases: myth or reality? , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[128]  E. Hatano,et al.  Implication of Frequent Local Ablation Therapy for Intrahepatic Recurrence in Prolonged Survival of Patients With Hepatocellular Carcinoma Undergoing Hepatic Resection: An Analysis of 610 Patients Over 16 Years Old , 2006, Annals of surgery.

[129]  S. Todo,et al.  Living Donor Liver Transplantation for Adult Patients With Hepatocellular Carcinoma: Experience in Japan , 2004, Annals of surgery.

[130]  K. Sugimachi,et al.  Impact of Des-Gamma-Carboxy Prothrombin and Tumor Size on the Recurrence of Hepatocellular Carcinoma After Living Donor Liver Transplantation , 2009, Transplantation.

[131]  K. Chijiiwa,et al.  Clinicopathologic Characteristics of Hepatocellular Carcinoma with Bile Duct Invasion , 2009, Journal of Gastrointestinal Surgery.

[132]  W. Lau,et al.  Preoperative Systemic Chemoimmunotherapy and Sequential Resection for Unresectable Hepatocellular Carcinoma , 2001, Annals of surgery.

[133]  P. Lainas,et al.  Laparoscopic hepatectomy for hepatocellular carcinoma: a European experience. , 2010, Journal of the American College of Surgeons.

[134]  G. Chau,et al.  Surgical treatment and outcome in patients with a hepatocellular carcinoma greater than 10 cm in diameter , 1998, The British journal of surgery.

[135]  Liver Cancer Study Group of Japan The general rules for the clinical and pathological study of primary liver cancer , 2006, The Japanese journal of surgery.

[136]  M. Makuuchi,et al.  Pre‐emptive antiviral therapy in living donor liver transplantation for hepatitis C: observation based on a single‐center experience , 2009, Transplant international : official journal of the European Society for Organ Transplantation.

[137]  M. Makuuchi,et al.  Prognostic Impact of Anatomic Resection for Hepatocellular Carcinoma , 2005, Annals of surgery.

[138]  G. Belli,et al.  Laparoscopic versus open liver resection for hepatocellular carcinoma in patients with histologically proven cirrhosis: short- and middle-term results , 2007, Surgical Endoscopy.

[139]  K Arai,et al.  Small hepatocellular carcinoma: treatment with subsegmental transcatheter arterial embolization. , 1993, Radiology.

[140]  L. Ferrell,et al.  HCV-related fibrosis progression following liver transplantation: increase in recent years. , 2000, Journal of hepatology.